Kyowa Kirin CPO Itagaki’s message for International Women’s Day People & Culture | March 7, 2025 Rare Disease Day 2025 - More Than You Can Imagine Patients | February,7, 2025 Kyowa Kirin CEO Miyamoto’s New Year Message: Accelerate Our Reforms with Determination for Delivering Life-changing...
The Kyowa Kirin Group is a Japanese pharma group that develops innovative specialty drugs, to raise the health and well-being of people around the world. Its flagship business Kyowa Kirin Co., Ltd. creates antibody-based drugs for cancer, kidney disease,
Kyowa Kirin pursues scientific breakthroughs to address unmet clinical needs. Learn more about our portfolio of specialty medicines in nephrology, oncology, immunology & allergy, and neurology. Join us to grow your career or partner with us to propel you
Kyowa Kirin pursues scientific breakthroughs to address unmet clinical needs. Learn more about our portfolio of specialty medicines in nephrology, oncology, immunology & allergy, and neurology. Join us to grow your career or partner with us to propel you
Ltd, a Kirin and Kyowa Kirin joint investment, have signed a preclinical joint research agreement to develop an LBP aimed at the prevention of necrotizing enterocolitis (NEC). This collaboration combines Siolta’s expertise in microbial science with Cowellnex’s institutional strength to advance ...
Kyowa Hakko Kirin will be a Japan-based Global Specialty Pharmaceutical Company contributing to human health and well-being worldwide through innovative drug discovery and global commercialization, driven by state-of-the art antibody technologies mainly in the core therapeutic areas of oncology, nephrolog...
Step three: Pre-clinical research By evaluating new ideas from every angle, from their effectiveness to their safety as a medicinal drug, we aim to create valuable, high-potential pharmaceuticals. Step four: Clinical development At Kyowa Kirin's development centres in Europe, the United States ...
Kyowa Kirin North America is a fully integrated specialty pharmaceutical company, where people work together to understand clinical needs and opportunities for innovation that can result in real advances for patients. Since 2018, the North American organization has received approval from the US Food and...
Kyowa Kirin aims to discover and deliver novel medicines and treatments with life-changing value. As a Japan-based Global Specialty Pharmaceutical Company, we have invested in drug discovery and biotechnology innovation for more than 70 years and are currently working to engineer the next generation ...
Understand the current and future drug revenue for Kyowa Kirin Co Ltd and assess market opportunity for new entrants with patient population 8-year forecasts. 13+ Regulatory Milestones Track drug and patent expiries along with geographies impacted. 12+ Insights Remove risk and uncertainty, gain ...